These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35395865)
1. Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors. Liu Y; Wang D; Li Z; Li X; Jin M; Jia N; Cui X; Hu G; Tang T; Yu Q Sci Rep; 2022 Apr; 12(1):5924. PubMed ID: 35395865 [TBL] [Abstract][Full Text] [Related]
2. The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer. Vallejo-Díaz J; Chagoyen M; Olazabal-Morán M; González-García A; Carrera AC Trends Cancer; 2019 Apr; 5(4):233-244. PubMed ID: 30961830 [TBL] [Abstract][Full Text] [Related]
3. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cheung LW; Hennessy BT; Li J; Yu S; Myers AP; Djordjevic B; Lu Y; Stemke-Hale K; Dyer MD; Zhang F; Ju Z; Cantley LC; Scherer SE; Liang H; Lu KH; Broaddus RR; Mills GB Cancer Discov; 2011 Jul; 1(2):170-85. PubMed ID: 21984976 [TBL] [Abstract][Full Text] [Related]
4. New routes to old places: PIK3R1 and PIK3R2 join PIK3CA and PTEN as endometrial cancer genes. Herrero-Gonzalez S; Di Cristofano A Cancer Discov; 2011 Jul; 1(2):106-7. PubMed ID: 22586352 [TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases. Dornan GL; Burke JE Front Immunol; 2018; 9():575. PubMed ID: 29616047 [TBL] [Abstract][Full Text] [Related]
6. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
7. Divergent roles of the regulatory subunits of class IA PI3K. Kim CW; Lee JM; Park SW Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714 [TBL] [Abstract][Full Text] [Related]
9. Circ_0000105 promotes liver cancer by regulating miR-498/PIK3R1. Sun Y; Sun X; Huang Q J Gene Med; 2020 Nov; 22(11):e3256. PubMed ID: 32729955 [TBL] [Abstract][Full Text] [Related]
10. The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity. Tsay A; Wang JC Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628845 [TBL] [Abstract][Full Text] [Related]
11. Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway. Turturro SB; Najor MS; Yung T; Portt L; Malarkey CS; Abukhdeir AM; Cobleigh MA Breast Cancer Res Treat; 2019 Sep; 177(2):325-333. PubMed ID: 31209687 [TBL] [Abstract][Full Text] [Related]
12. Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis. Yu Y; Sun X; Chen F; Liu M Front Genet; 2022; 13():812674. PubMed ID: 35126480 [TBL] [Abstract][Full Text] [Related]
13. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway. Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384 [TBL] [Abstract][Full Text] [Related]
15. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Chi Y; Xue J; Huang S; Xiu B; Su Y; Wang W; Guo R; Wang L; Li L; Shao Z; Jin W; Wu Z; Wu J Theranostics; 2019; 9(23):6840-6855. PubMed ID: 31660072 [No Abstract] [Full Text] [Related]
16. PIK3R1 underexpression is an independent prognostic marker in breast cancer. Cizkova M; Vacher S; Meseure D; Trassard M; Susini A; Mlcuchova D; Callens C; Rouleau E; Spyratos F; Lidereau R; Bièche I BMC Cancer; 2013 Nov; 13():545. PubMed ID: 24229379 [TBL] [Abstract][Full Text] [Related]
17. Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK. Tran KB; Kolekar S; Jabed A; Jaynes P; Shih JH; Wang Q; Flanagan JU; Rewcastle GW; Baguley BC; Shepherd PR BMC Cancer; 2021 Feb; 21(1):136. PubMed ID: 33549048 [TBL] [Abstract][Full Text] [Related]
18. Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases. Dornan GL; Stariha JTB; Rathinaswamy MK; Powell CJ; Boulanger MJ; Burke JE Structure; 2020 Feb; 28(2):145-156.e5. PubMed ID: 31831213 [TBL] [Abstract][Full Text] [Related]
19. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Weber GL; Parat MO; Binder ZA; Gallia GL; Riggins GJ Oncotarget; 2011 Nov; 2(11):833-49. PubMed ID: 22064833 [TBL] [Abstract][Full Text] [Related]
20. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer. Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591 [No Abstract] [Full Text] [Related] [Next] [New Search]